Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 503942, 8 pages
http://dx.doi.org/10.1155/2012/503942
Clinical Study

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders

1Dipartimento di Malattie Infettive, Parassitarie ed Immunomediate, Istituto Superiore di Sanità, 00161 Rome, Italy
2Dipartimento di Medicina Interna e Specialità Mediche, Reumatologia, Sapienza Università di Roma, 00185 Rome, Italy
3Dipartimento di Sanità Pubblica Veterinaria e Sicurezza Alimentare, Istituto Superiore di Sanità, 00161 Rome, Italy
4Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, 00161 Rome, Italy
5Dipartimento di Fisiologia e Farmacologia “Vittorio Erspamer”, Sapienza Università di Roma, 00185 Rome, Italy

Received 26 July 2011; Revised 27 October 2011; Accepted 18 November 2011

Academic Editor: Muzamil Ahmad

Copyright © 2012 Elisabetta Profumo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Lourida, A. N. Georgiadis, E. C. Papavasiliou, A. I. Papathanasiou, A. A. Drosos, and A. D. Tselepis, “Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2,” Arthritis Research and Therapy, vol. 9, no. 1, p. R19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Gabriel, C. S. Crowson, H. M. Kremers et al., “Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years,” Arthritis and Rheumatism, vol. 48, no. 1, pp. 54–58, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. P. M. Symmons, “Looking back: Rheumatoid arthritis—aetiology, occurrence and mortality,” Rheumatology, vol. 44, no. 4, pp. iv14–iv17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Van Doornum, G. McColl, and I. P. Wicks, “Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?” Arthritis and Rheumatism, vol. 46, no. 4, pp. 862–873, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo et al., “HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis,” American Journal of Medicine, vol. 114, no. 8, pp. 647–652, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Ritchlin, “Psoriatic disease - From skin to bone,” Nature Clinical Practice Rheumatology, vol. 3, no. 12, pp. 698–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Gonzalez-Juanatey, J. Llorca, J. A. Miranda-Filloy et al., “Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors,” Arthritis and Rheumatism, vol. 57, no. 2, pp. 287–293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Kimhi, D. Caspi, N. M. Bornstein et al., “Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis,” Seminars in Arthritis and Rheumatism, vol. 36, no. 4, pp. 203–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Gállego, E. Martínez Vila, and R. Muñoz, “Patients at high risk for ischemic stroke: identification and actions,” Cerebrovascular Diseases, vol. 24, no. 1, pp. 49–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Pearson, “New tools for coronary risk assessment: what are their advantages and limitations?” Circulation, vol. 105, no. 7, pp. 886–892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. B. Assayag, I. Bova, A. Kesler, S. Berliner, I. Shapira, and N. M. Bornstein, “Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis,” Disease Markers, vol. 24, no. 1, pp. 33–39, 2008. View at Google Scholar · View at Scopus
  12. S. D. de Ferranti and N. Rifai, “C-reactive protein: a nontraditional serum marker of cardiovascular risk,” Cardiovascular Pathology, vol. 16, no. 1, pp. 14–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kabuyama, T. Kitamura, J. Yamaki, M. K. Homma, S. I. Kikuchi, and Y. Homma, “Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells,” Biochemical and Biophysical Research Communications, vol. 367, no. 2, pp. 491–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Firuzi, L. Fuksa, C. Spadaro et al., “Oxidative stress parameters in different systemic rheumatic diseases,” Journal of Pharmacy and Pharmacology, vol. 58, no. 7, pp. 951–957, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Profumo, B. Buttari, M. E. Tosti et al., “Subclinical atherosclerosis in patients with rheumatoid and psoriatic arthritis,” in Autoimmunity: Role, Regulation and Disorders, F. L. Vogel and L. F. Zimmermann, Eds., Nova Science, 2008. View at Google Scholar
  16. M. A. Gonzales-Gay, J. Llorca, R. Palomino-Morales, I. Gomez-Acebo, C. Gonzales-Juanatey, and J. Martin, “Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovasular events in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 27, no. 1, pp. 116–119, 2009. View at Google Scholar · View at Scopus
  17. E. W. Karlson, N. A. Shadick, N. R. Cook, J. E. Buring, and I. M. Lee, “Vitamin E in the primary prevention of rheumatoid arthritis: the women's health study,” Arthritis Care and Research, vol. 59, no. 11, pp. 1589–1595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  19. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants, “Classification criteria for psoriatic arthritis: development of new criteria from a large international study,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2665–2673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. van Sijl, M. J. Peters, D. K. Knol et al., “Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis,” Seminars in Arthritis and Rheumatism, vol. 40, no. 5, pp. 389–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Gonzalez-Juanatey, J. Llorca, E. Amigo-Diaz, T. Dierssen, J. Martin, and M. A. Gonzalez-Gay, “High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors,” Arthritis Care and Research, vol. 57, no. 6, pp. 1074–1080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Gonzalez-Juanatey, J. Llorca, J. Martin, and M. A. Gonzalez-Gay, “Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 38, no. 5, pp. 366–371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Espeland, H. Hoen, R. Byington, G. Howard, W. A. Riley, and C. D. Furberg, “Spatial distribution of carotid intimal-medial thickness as measured by B- mode ultrasonography,” Stroke, vol. 25, no. 9, pp. 1812–1819, 1994. View at Google Scholar · View at Scopus
  24. E. Gimeno, A. I. Castellote, R. M. Lamuela-Raventós, M. C. De la Torre-Boronat, and M. C. López-Sabater, “Rapid high-performance liquid chromatographic method for the simultaneous determination of retinol, α-tocopherol and β-carotene in human plasma and low-density lipoproteins,” Journal of Chromatography B, vol. 758, no. 2, pp. 315–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Cavina, B. Galinella, R. Porra, P. Pecora, and C. Suraci, “Carotenoids, retinoids and alpha-tocopherol in human serum: identification and determination by reversed-phase HPLC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 6, no. 3, pp. 259–269, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, M. J. Lopez-Diaz et al., “HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis,” Arthritis Care and Research, vol. 57, no. 1, pp. 125–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Van Zonneveld, H. C. De Boer, E. P. Van Der Veer, and T. J. Rabelink, “Inflammation, vascular injury and repair in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. i57–i60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Nagy, A. Koncz, T. Telarico et al., “Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 12, no. 3, p. 210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Steinberg, “The LDL modification hypothesis of atherogenesis: an update,” Journal of Lipid Research, vol. 50, pp. S376–S381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Stocker and J. F. Keaney, “Role of oxidative modifications in atherosclerosis,” Physiological Reviews, vol. 84, no. 4, pp. 1381–1478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Karppi, T. Nurmi, S. Kurl, T. H. Rissanen, and K. Nyyssönen, “Lycopene, lutein and β-carotene as determinants of LDL conjugated dienes in serum,” Atherosclerosis, vol. 209, no. 2, pp. 565–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. W. Choi, “Nitric oxide production is increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity,” Clinica Chimica Acta, vol. 336, no. 1-2, pp. 83–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Gonzalez-Gay, M. T. Garcia-Unzueta, A. Berja et al., “Short-term effect of anti-TNF-α therapy on nitric oxide production in patients with severe rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 27, no. 3, pp. 452–458, 2009. View at Google Scholar · View at Scopus
  34. N. Vuilleumier, J. Bratt, R. Alizadeh, T. Jogestrand, I. Hafström, and J. Frostegård, “Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity,” Scandinavian Journal of Rheumatology, vol. 39, no. 6, pp. 447–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Zadák, R. Hyšpler, A. Tichá et al., “Antioxidants and vitamins in clinical conditions,” Physiological Research, vol. 58, no. 1, pp. S13–S17, 2009. View at Google Scholar · View at Scopus
  36. W. E. Brady, J. A. Mares-Perlman, P. Bowen, and M. Stacewicz-Sapuntzakis, “Human serum carotenoid concentrations are related to physiologic and lifestyle factors,” Journal of Nutrition, vol. 126, no. 1, pp. 129–137, 1996. View at Google Scholar · View at Scopus
  37. H. Tapiero, D. M. Townsend, and K. D. Tew, “The role of carotenoids in the prevention of human pathologies,” Biomedicine and Pharmacotherapy, vol. 58, no. 2, pp. 100–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. Costenbader, J. H. Kang, and E. W. Karlson, “Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women,” American Journal of Epidemiology, vol. 172, no. 2, pp. 205–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. De Pablo, T. Dietrich, and E. W. Karlson, “Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample,” Arthritis Care and Research, vol. 57, no. 6, pp. 953–962, 2007. View at Publisher · View at Google Scholar · View at Scopus